Evidence map›Paper›PMID 42706520›Full record

ArticleBMC public health2026

Effectiveness of an on-site vaccination campaign for patients with cancer.

Theresa Markus, Sarah Eitze, Ruth Flümann, Philipp Gödel, Michael Hallek, Sebastian Herrmann, Udo Holtick, Jonathan Köllges, Petra Langerbeins, Janina Leckler and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Theresa MarkusInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Sarah EitzeInstitute for Planetary Health Behaviour, University of Erfurt, Erfurt, Germany.
Ruth FlümannFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Philipp GödelFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Michael HallekFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Sebastian HerrmannInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Udo HoltickFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Jonathan KöllgesInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Petra LangerbeinsFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Janina LecklerInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Clara LehmannFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Nathalie LehnenFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Ben MechtelInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Johanna PrinzFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Tim RichardsonFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Jan RybnikerFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Jon Salmanton-GarcíaInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Rosanne SpruteInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Jonathan SteinkeFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Jannik StemlerInstitute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Thomas ZanderFaculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, University of Cologne and Centre for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Centre for Medical Mycology (ECMM), University of Cologne, Cologne, Germany.
Oliver A Cornely *Institute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
Sibylle C Mellinghoff *Institute of Translational Research, Cologne Excellence Cluster On Cellular Stress Responses in Aging-Associated Diseases (CECAD), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany. Sibylle.mellinghoff@uk-koeln.de.ORCID 0000-0003-3928-2503

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with haematological or oncological malignancies are at increased risk of severe infections. Vaccination is a key preventive strategy and is recommended by National Immunization Technical Advisory Groups (NITAGs). Yet, vaccination rates in this population remain improvable. This project aimed to evaluate and enhance vaccine uptake in cancer patients.

methodsWe conducted a pre- and post-observational study at the University Hospital Cologne in Germany to assess vaccination status over a 1.5-year intervention. Relevant infections included COVID-19, influenza, herpes zoster, pneumococci and RSV. The campaign included patient education, staff training, on-site vaccination, and targeted promotional efforts.

resultsA total of 749 patients were included (n = 398 in 2023, n = 351 in 2025). Overall vaccination rates increased from 43 to 49%, while COVID-19 vaccine coverage remained above 90%. Notable increases were observed for influenza (37% to 48%), pneumococcal (16% to 36%), and herpes zoster (22% to 33%) vaccines. The proportion of patients fully vaccinated according to public health recommendations rose from 6 to 16%, whereas those completely unvaccinated remained low (4% to 6%).

conclusionFocused vaccination campaigns can effectively increase vaccine uptake in patients with cancer; however, the proportion of individuals vaccinated per recommended schedule remains low. Future research should investigate barriers and reasons for vaccine refusal to guide more targeted interventions.

Indexed as

Immunization ProgramsNeoplasmsVaccinationAdultAgedAged, 80 and overCOVID-19COVID-19 VaccinesFemaleGermanyHumansMaleMiddle AgedProgram EvaluationCOVID-19 VaccinesCOVID-19Haematology and oncologyHerpes zosterInfluenzaPneumococcalVaccination ratesVaccine campaign

Identifiers

PMID42706520
PMCPMC13551785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.